IN BRIEF: Goodwin Procter, Willkie Farr & Gallagher, Winston & Strawn, advised on the matter. Goodwin Procter advised SEVETYS with a team including Adrien Paturaud (Finance)....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Bregal Sagemount on the deal. Bregal Sagemount announced its equity investment in Transflo. Bregal Sagemount is a growth focused private capital firm with $4...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Global Blood Therapeutics on the deal. Global Blood Therapeutics, Inc. (Nasdaq: GBT) announced its offering of 1.875% Convertible Senior Notes due 2028. The...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Automation Anywhere on the deal. Automation Anywhere, a global leader in robotic process automation (RPA), announced that it has entered...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Depixus on the deal. Depixus, a French life science tools company, announced its €30.6 million Series A financing led by Bpifrance and Lansdowne Partners....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Genfit on the deal. Genfit entered into a licensing agreement with Genoscience Pharma for exclusive right to develop and commercialize the investigational treatment...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Emmet, Marvin & Martin, LLP, Giovannelli e Associati Studio Legale, Goodwin Procter, Loeb & Loeb LLP, Spada Partners, advised on the matter. Emmet, Marvin...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters on the deal. Genenta Science S.p.A.’s (Nasdaq: GNTA) announced its upsized initial public offering, making history as the first Italian biotech to...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised SWORD Health on the deal. SWORD Health announced its Series D financing. This brings the total primary and secondary transactions to more than $320...
You must be a Standard 1 Year member to access this content.
Bär & Karrer acts as legal advisor to the founding shareholders of Appway in this transaction. Goodwin Procter advised Summit Partners. Homburger advised FNZ in this...
You must be a Standard 1 Year member to access this content.
